Clarius Group LLC’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-18,620
| Closed | -$4.28K | – | 505 |
|
|
2024
Q4 | $4.28K | Hold |
18,620
| – | – | ﹤0.01% | 452 |
|
|
2024
Q3 | $40K | Hold |
18,620
| – | – | ﹤0.01% | 452 |
|
|
2024
Q2 | $96.1K | Hold |
18,620
| – | – | 0.01% | 436 |
|
|
2024
Q1 | $99.6K | Hold |
18,620
| – | – | 0.01% | 474 |
|
|
2023
Q4 | $145K | Hold |
18,620
| – | – | 0.01% | 463 |
|
|
2023
Q3 | $73.5K | Buy |
+18,620
| New | +$73.5K | 0.01% | 451 |
|
|
2023
Q2 | – | Sell |
-18,620
| Closed | -$49.7K | – | 524 |
|
|
2023
Q1 | $49.7K | Hold |
18,620
| – | – | ﹤0.01% | 502 |
|
|
2022
Q4 | $67K | Sell |
18,620
-727
| -4% | -$2.62K | 0.01% | 501 |
|
|
2022
Q3 | $125K | Sell |
19,347
-1
| -0% | -$6 | 0.01% | 470 |
|
|
2022
Q2 | $186K | Buy |
+19,348
| New | +$186K | 0.02% | 448 |
|